Cargando…
Construction of doxycyline-dependent mini-HIV-1 variants for the development of a virotherapy against leukemias
T-cell acute lymphoblastic leukemia (T-ALL) is a high-risk type of blood-cell cancer. We describe the improvement of a candidate therapeutic virus for virotherapy of leukemic cells. Virotherapy is based on the exclusive replication of a virus in leukemic cells, leading to the selective removal of th...
Autores principales: | Jeeninga, Rienk E, Jan, Barbara, van den Berg, Henk, Berkhout, Ben |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1592508/ https://www.ncbi.nlm.nih.gov/pubmed/17005036 http://dx.doi.org/10.1186/1742-4690-3-64 |
Ejemplares similares
-
Differential proviral latency of the HIV-1 subtypes B and AE
por: van der Sluis, Renée M, et al.
Publicado: (2011) -
RNAi strategies to silence HIV-1
por: Eekels, Julia, et al.
Publicado: (2011) -
Latency profiles of full length HIV-1 molecular clone variants with a subtype specific promoter
por: van der Sluis, Renée M, et al.
Publicado: (2011) -
HIV-1 latency in actively dividing human T cell lines
por: Jeeninga, Rienk E, et al.
Publicado: (2008) -
Transient CRISPR-Cas Treatment Can Prevent Reactivation of HIV-1 Replication in a Latently Infected T-Cell Line
por: Liu, Ye, et al.
Publicado: (2021)